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applying techniques that allow sparing
critical tissues and appropriate dose
distribution in planning target volume. The
most attractive seems to be Intensity?
Modulated Radiosurgery (IMRS). IMRT is
a treatment modality that uses varying
energy fluence across the field to assure
better conformity and steeper dose
gradients than techniques based solely on
geometric field shaping. The indications for
its use are still discussed, especially in
conjunction with stereotactic radiosurgery.
Objective. The aim of our study was to
analyze treatment plans in order to find the
most frequent situations when intensity
modulation was used and, thus, to
determine the possible indications for
IMRS.
Material and Methods. Thirty-three
treatment plans of IMRS of 220 made for
radiosurgery between October 2001 and
February 2003 were analyzed.
Results. IMRS was most commonly
used when target volume was localized in
the vicinity of organs at risk (17 cases -
51%). In 7 of these cases the need for
intensity modulation was caused both by
the necessity of sparing organs at risk and
geometric complexity of irradiated volume.
In 15 cases (45%), including the men-
tioned above, complex shape of target
volume was the reason of intensity
modulation application. In 4 cases (12%) -
multiple target volumes (2-4) - in brain
metastases and bifocal recurrence of
malignant glioma. In 3 cases (9%) - dose
escalation within the irradiated volume
(boost on gross tumor volume inside the
PTV). In two cases the use of intensity
modulation was the only way to obtain
optimal dose distribution in the target
volume of simple shape, located away of
organs at risk
Conclusions. Intensity modulation in ra-
diosurgery is a very attractive option when
there is a need for irradiation volumes
close to organs at risk. It is also useful
when "conventional" conformal techniques
cannot assure optimal dose distribution in
target volumes of complex shapes. Finally,
it is a convenient way to boost gross tumor
volume inside the PTV when prescribed
dose is delivered in single fraction.
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RADICAL RADIOTHERAPY FOR
MUSCLE-INVASIVE BLADDER CAN-
CER: THE INFLUENCE OF TOTAL
RADIATION DOSE AND OVERALL
TREATMENT TIME ON DISEASE
OUTCOME.
Majewski W.
Radiotherapy Department, Center of Oncology,
Maria Sklodowska-Curie Memorial Institute,
Branch in Gliwice
Purpose: To assess the influence of
total radiation dose, overall tratment time
and other clinical factors on treatment
outcome for muscle-invasive (T2,T3)
bladder cancer patients, treated with
radical radiotherapy.
Material and methods: Between 1975
and 1995, 480 consecutive patients with
T2, T3 bladder cancer were treated with
radical radiotherapy. During that period
various fractionation schedules were used:
1. conventional fractionation (once a-day,
1.8-2.5 Gy/fraction; OTT-53 days), 2.
protracted fractionation (once a-day,
pelvis- 1.6-1.7 Gy/fraction, boost- 2.0
Gy/fraction; OTT-62 days), 3. accelerated
hyperlractionated boost (pelvis- once a-
day, 2.0 Gy/fraction; boost- twice a-day,
1.3-1.4 Gy/fraction; OTT-45 days), 4.
accelerated hyperlractionation (pelvis and
boost- twice a-day, 1.2-1.5 Gy/fraction;
OTT-41 days). For the whole group of
patients mean total dose and mean overall
treatment time were: 65.5 Gy and 51 days,
respectively. Maximum-likelihood logistic
model and Cox proportional hazard model
were used to evaluate the role of total
dose, overall treatment time, T-stage,
hemoglobin level and bladder capacity
before radiotherapy. The median follow-up
was 76 months.
Results: Five-years actuarial local
control rate was 47% and overall survival
rate was 40%. Logistic model including
total dose, overall treatment time and T-
stage revealed that all those factors
significantly influenced local control
probability (p=0.021 for TO, p=0.038 for
OTT and p=0.00068 for T-stage). When
other clinical factors and tratment-related
parameters were analysed in Cox
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proportional hazard model the results were
as follows: Hb-Ievel and bladder capacity
before radiotherapy significantly influenced
local control and overall survival, total
radiation dose was of borderline signifi-
cance for overall survival (p=0.065) but
overall treatment time was not significant
parameter.
Conclusions: Our study suggest that,
higher total radiation dose may be related
to better treatment outcome. The effect of
overall treatment time is difficult to define,
because its role depends on influence of
other prognostic factors. The most
important factors for treatment outcome
are: hemoglobin level, bladder capacity
before radiotherapy and T-stage.
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1H-MR SPECTROSCOPY OF NOR-
MAL BRAIN TISSUE BEFORE AND
AFTER POSTOPERATIVE
RADIOTHERAPY FOR PRIMARY
BRAIN TUMORS
Rutkowski T., Tarnawski R., SokOl M.
Center of Oncology Maria Skfodowska-Curie
Institute branch Gliwice
Purpose: The aim of the study was to
reveal the impact of postoperative
radiotherapy (pRT) on normal brain tissue
metabolism and find out, if proton
magnetic resonance spectroscopy (1 H-
MRS) can help in delineating tumor
recurrence area.
Methods and Material: Spectra of 43
patients treated with pRT for glial tumors
assessed by 1H-MRS were analyzed.
Patients were treated with conformal 3D
techniques using 6-20 MV photons to the
total dose of 60 -Gy given in 30 fractions.
Control group consisted of spectra
registered for 30 healthy volunteers.
Spectra were taken from tumor bed and
from control region before pRT and from a
3 uninvolved regions 9-12 months after the
end of pRT. Voxels were located in the
region of low, medium and high total dose.
Relative intensities of the signals due to N-
acetyl aspartate (NAA), choline based
compounds (Cho), mia-Inositol (ml),
lactate (Lac) and lipids (Lip) were
obtained. The statistical difference be-
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tween means was calculated using Mann-
Whitney U-test for independent samples or
paired Wilcoxon test for the different dose
levels for one patient.
Results: Spectra taken after pRT were
significantly different from those obtained
from healthy volunteers and those
acquired before radiotherapy. The lactate
and lipids signals were strong and not
correlated with absorbed dose. NANCr
ratios were significantly lower than before
pRT even for the low dose regions. These
differences were increasing with radiation
dose. Cho/Cr and Cho/NAA ratios
increased significantly in medium and high
dose area.
Conclusion: 1H-MRS can not help in
delineating tumor recurrence area after
pRT. Surgery and pRT cause alteration of
brain metabolism even in regions far from
the postoperative tumor bed that received
relatively low total radiation dose.
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ROLA CZYNNIKOW WZROSTU
DZIAt..AJ~CYCH POPRZEZ
RECEPTORY 0 WEWN~TRZNEJ
AKTYWNOSCI KINAZY
TYROZYNOWEJ W WYBRANYCH
CHOROBACH ROZROSTOWYCH
UKI:..ADU KRWIOTWORCZEGO
Kawa M., Marlicz W., Karbidka A.,
Baskiewicz-Masiuk M., Machalinska A.,
Machalinski B.
Zaktad Patologii Og6lnej, Pomorska Akademia
Medyczna, al. Powstancow Wlkp. 72,
70-111 Szczecin
Zaloi:enia i cel pracy: Cytokiny dziatajq-
ce poprzez receptory kom6rkowe 0 wew-
n~trznej aktywnosci kinazy tyrozynowej
(TKRs) regulujq wczesne etapy
hematopoezy. Wsr6d nich wyr6i:niamy:
insulin~ (INS), somatomedyny (IGF),
ligand receptora C-KIT (KL,SCF), czynniki
wzrostu fibroblast6w (FGF), czynnik
wzrostu hepatocyt6w (HGF), neutrofin~
(NGF), p1ytkowy czynnik wzrostu (PDGF),
makrofagopoetyn~ (CSF-1). Prawidfowe
kom6rki hematopoetyczne syntetyzujq
samodzielnie czynniki wzrostu podlegajqc
dziataniu p~tli autokrynnych. Nie rna
danych, czy wzrost kom6rek biatacz-
S259
